Ticker Sage

Filings news · ABBV

AbbVie filings

Notes on AbbVie's new 8-K reports, insider trades on Form 4, and large-holder reports. For the business itself, see the AbbVie company file.

  1. Oct 154:00 PM ET

    8-K

    AbbVie files an 8-K on director or officer changes

    AbbVie filed a Form 8-K on Oct 15, 2026 at 4:00 PM ET under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).

  2. Oct 54:07 PM ET

    8-K

    AbbVie files an 8-K on quarterly results

    AbbVie filed a Form 8-K on Oct 5, 2026 at 4:07 PM ET under Item 2.02 (Results of Operations and Financial Condition).

  3. Oct 25:00 PM ET

    Form 4

    AbbVie director Susan E. Quaggin reports an award of 59 stock Equivalent units

    The filing reports 59 stock Equivalent units in a grant or award (code A).

  4. Oct 25:00 PM ET

    Form 4

    AbbVie director Edward J. Rapp reports an award of 129 stock Equivalent units

    The filing reports 129 stock Equivalent units in a grant or award (code A).